Adtalem Global Education Inc. reported first‑quarter fiscal 2026 results for the period ending September 30, 2025, with revenue of $462.3 million, up 10.8% from $417.4 million in the same quarter of fiscal 2025. Diluted earnings per share were $1.67, and adjusted earnings per share rose 35.7% to $1.75, compared with $1.29 in the prior year.
Chamberlain University generated $179.2 million in revenue and $25.6 million in operating income. Walden University contributed $190.0 million in revenue and $53.3 million in operating income, while Medical & Veterinary reported $93.1 million in revenue and $16.7 million in operating income. Enrollment growth continued across all segments, with Walden achieving its highest total enrollment to date.
Net cash provided by operating activities was $130.6 million. The company repurchased $8 million of shares during the quarter, leaving $142 million under its share‑repurchase program. It also increased its revolving credit facility and reduced its Term Loan B balance, reinforcing its balance‑sheet strength.
Adtalem reaffirmed its fiscal‑year 2026 guidance, projecting revenue of $1.90 billion to $1.94 billion and adjusted earnings per share of $7.60 to $7.90. The guidance remains unchanged from the August 2025 update. An investor day is scheduled for February 24, 2026 to discuss long‑term strategy and capital allocation plans.
The company’s “Growth with Purpose” strategy focuses on expanding healthcare education to address workforce shortages. Recent partnerships, including a collaboration with Google Cloud for AI‑enabled healthcare credentials, support this strategic direction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.